These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34458588)

  • 1. Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
    Tindana P; de Haan F; Mokuolu OA; Guissou R; Bolarinwa OA; Ouedraogo JB; Tou F; Boon WPC; Moors EHM; Dondorp AM; Dhorda M; Amaratunga C; Cheah PY
    Wellcome Open Res; 2021; 6():75. PubMed ID: 34458588
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.
    Tindana P; Guissou R; Bolarinwa OA; Tou F; de Haan F; Dhorda M; Dondorp AM; Amaratunga C; Mokuolu OA; Ouedraogo JB; Cheah PY
    PLoS One; 2022; 17(9):e0273249. PubMed ID: 36083995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
    de Haan F; Bolarinwa OA; Guissou R; Tou F; Tindana P; Boon WPC; Moors EHM; Cheah PY; Dhorda M; Dondorp AM; Ouedraogo JB; Mokuolu OA; Amaratunga C
    PLoS One; 2021; 16(8):e0256567. PubMed ID: 34464398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.
    Ishengoma DS; Mandara CI; Bakari C; Fola AA; Madebe RA; Seth MD; Francis F; Buguzi C; Moshi R; Garimo I; Lazaro S; Lusasi A; Aaron S; Chacky F; Mohamed A; Njau RJA; Kitau J; Rasmussen C; Bailey JA; Juliano JJ; Warsame M
    medRxiv; 2024 Feb; ():. PubMed ID: 38352311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study.
    de Haan F; Boon WPC; Amaratunga C; Dondorp AM
    BMC Public Health; 2022 Apr; 22(1):864. PubMed ID: 35490212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria.
    Mokuolu OA; Bolarinwa OA; Opadiran OR; Ameen HA; Dhorda M; Cheah PY; Amaratunga C; de Haan F; Tindana P; Dondorp AM
    Malar J; 2023 Jun; 22(1):185. PubMed ID: 37330469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso.
    Guissou RM; Amaratunga C; de Haan F; Tou F; Cheah PY; Yerbanga RS; Moors EHM; Dhorda M; Tindana P; Boon WPC; Dondorp AM; Ouédraogo JB
    Malar J; 2023 Sep; 22(1):269. PubMed ID: 37705004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations.
    Tindana P; de Haan F; Amaratunga C; Dhorda M; van der Pluijm RW; Dondorp AM; Cheah PY
    Malar J; 2021 Feb; 20(1):119. PubMed ID: 33639946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso.
    Kaboré JMT; Siribié M; Hien D; Soulama I; Barry N; Baguiya A; Tiono AB; Burri C; Tchouatieu AM; Sirima SB
    Trop Med Infect Dis; 2023 Mar; 8(4):. PubMed ID: 37104321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion.
    de Haan F; Amaratunga C; Thi VAC; Orng LH; Vonglokham M; Quang TN; Lek D; Boon WPC; Dondorp AM; Moors EHM
    Malar J; 2023 Sep; 22(1):261. PubMed ID: 37674172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsidising artemisinin-based combination therapy in the private retail sector.
    Opiyo N; Yamey G; Garner P
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
    Hien D; Kaboré JMT; Siribié M; Soulama I; Barry N; Baguiya A; Tiono AB; Tchouatieu AM; Sirima SB
    Malar J; 2022 Jun; 21(1):202. PubMed ID: 35761273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.
    Siribie M; Tchouatieu AM; Soulama I; Kaboré JMT; Nombré Y; Hien D; Kiba Koumaré A; Barry N; Baguiya A; Héma A; Dianda F; Savadogo Y; Kouanda S; Tiono AB; Sirima SB
    BMJ Open; 2021 Feb; 11(2):e040220. PubMed ID: 33589447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam.
    Cao VAT; Nguyen TQ; Le Quyen D; Boon WPC; Moors EHM; Dondorp AM; de Haan F; Amaratunga C
    Malar J; 2023 Oct; 22(1):326. PubMed ID: 37898749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing antimalarial drug resistance with triple artemisinin-based combination therapies.
    Nguyen TD; Gao B; Amaratunga C; Dhorda M; Tran TN; White NJ; Dondorp AM; Boni MF; Aguas R
    Nat Commun; 2023 Jul; 14(1):4568. PubMed ID: 37516752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.
    Kachur SP; Black C; Abdulla S; Goodman C
    Malar J; 2006 Mar; 5():25. PubMed ID: 16569252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.